462 related articles for article (PubMed ID: 20539944)
21. miR-152 controls migration and invasive potential by targeting TGFα in prostate cancer cell lines.
Zhu C; Li J; Ding Q; Cheng G; Zhou H; Tao L; Cai H; Li P; Cao Q; Ju X; Meng X; Qin C; Hua L; Shao P; Yin C
Prostate; 2013 Jul; 73(10):1082-9. PubMed ID: 23460133
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA alteration and putative target genes in high-grade prostatic intraepithelial neoplasia and prostate cancer: STAT3 and ZEB1 are upregulated during prostate carcinogenesis.
Cha YJ; Lee JH; Han HH; Kim BG; Kang S; Choi YD; Cho NH
Prostate; 2016 Jul; 76(10):937-47. PubMed ID: 27017949
[TBL] [Abstract][Full Text] [Related]
23. Hypoxia-responsive miR-124 and miR-144 reduce hypoxia-induced autophagy and enhance radiosensitivity of prostate cancer cells via suppressing PIM1.
Gu H; Liu M; Ding C; Wang X; Wang R; Wu X; Fan R
Cancer Med; 2016 Jun; 5(6):1174-82. PubMed ID: 26990493
[TBL] [Abstract][Full Text] [Related]
24. miR-326 functions as a tumor suppressor in human prostatic carcinoma by targeting Mucin1.
Liang X; Li Z; Men Q; Li Y; Li H; Chong T
Biomed Pharmacother; 2018 Dec; 108():574-583. PubMed ID: 30243091
[TBL] [Abstract][Full Text] [Related]
25. The emerging role of miR-506 in cancer.
Li J; Ju J; Ni B; Wang H
Oncotarget; 2016 Sep; 7(38):62778-62788. PubMed ID: 27542202
[TBL] [Abstract][Full Text] [Related]
26. Activin A regulates microRNAs and gene expression in LNCaP cells.
Ottley EC; Nicholson HD; Gold EJ
Prostate; 2016 Aug; 76(11):951-63. PubMed ID: 27018851
[TBL] [Abstract][Full Text] [Related]
27. Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway.
Ren D; Yang Q; Dai Y; Guo W; Du H; Song L; Peng X
Mol Cancer; 2017 Jul; 16(1):117. PubMed ID: 28693582
[TBL] [Abstract][Full Text] [Related]
28. miRNAs and cancer: New research developments and potential clinical applications.
Erson AE; Petty EM
Cancer Biol Ther; 2009 Dec; 8(24):2317-22. PubMed ID: 20168083
[TBL] [Abstract][Full Text] [Related]
29. miR-125b acts as a tumor suppressor in breast tumorigenesis via its novel direct targets ENPEP, CK2-α, CCNJ, and MEGF9.
Feliciano A; Castellvi J; Artero-Castro A; Leal JA; Romagosa C; Hernández-Losa J; Peg V; Fabra A; Vidal F; Kondoh H; Ramón Y Cajal S; Lleonart ME
PLoS One; 2013; 8(10):e76247. PubMed ID: 24098452
[TBL] [Abstract][Full Text] [Related]
30. The microRNA profile of prostate carcinoma obtained by deep sequencing.
Szczyrba J; Löprich E; Wach S; Jung V; Unteregger G; Barth S; Grobholz R; Wieland W; Stöhr R; Hartmann A; Wullich B; Grässer F
Mol Cancer Res; 2010 Apr; 8(4):529-38. PubMed ID: 20353999
[TBL] [Abstract][Full Text] [Related]
31. MiRNAs regulate oxidative stress related genes via binding to the 3' UTR and TATA-box regions: a new hypothesis for cataract pathogenesis.
Wu C; Liu Z; Ma L; Pei C; Qin L; Gao N; Li J; Yin Y
BMC Ophthalmol; 2017 Aug; 17(1):142. PubMed ID: 28806956
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-212 negatively regulates starvation induced autophagy in prostate cancer cells by inhibiting SIRT1 and is a modulator of angiogenesis and cellular senescence.
Ramalinga M; Roy A; Srivastava A; Bhattarai A; Harish V; Suy S; Collins S; Kumar D
Oncotarget; 2015 Oct; 6(33):34446-57. PubMed ID: 26439987
[TBL] [Abstract][Full Text] [Related]
33. miR-539 inhibits prostate cancer progression by directly targeting SPAG5.
Zhang H; Li S; Yang X; Qiao B; Zhang Z; Xu Y
J Exp Clin Cancer Res; 2016 Apr; 35():60. PubMed ID: 27037000
[TBL] [Abstract][Full Text] [Related]
34. Role of microRNA-410 in molecular oncology: A double edged sword.
Wen R; Umeano AC; Essegian DJ; Sabitaliyevich UY; Wang K; Farooqi AA
J Cell Biochem; 2018 Nov; 119(11):8737-8742. PubMed ID: 30086210
[TBL] [Abstract][Full Text] [Related]
35. DDX6 post-transcriptionally down-regulates miR-143/145 expression through host gene NCR143/145 in cancer cells.
Iio A; Takagi T; Miki K; Naoe T; Nakayama A; Akao Y
Biochim Biophys Acta; 2013 Oct; 1829(10):1102-10. PubMed ID: 23932921
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation.
Lee KH; Chen YL; Yeh SD; Hsiao M; Lin JT; Goan YG; Lu PJ
Oncogene; 2009 Sep; 28(38):3360-70. PubMed ID: 19597470
[TBL] [Abstract][Full Text] [Related]
37. MiR-26b inhibits autophagy by targeting ULK2 in prostate cancer cells.
John Clotaire DZ; Zhang B; Wei N; Gao R; Zhao F; Wang Y; Lei M; Huang W
Biochem Biophys Res Commun; 2016 Mar; 472(1):194-200. PubMed ID: 26920049
[TBL] [Abstract][Full Text] [Related]
38. MiR-1271 Inhibits Cell Growth in Prostate Cancer by Targeting ERG.
Wang M; Gao W; Lu D; Teng L
Pathol Oncol Res; 2018 Apr; 24(2):385-391. PubMed ID: 28551819
[TBL] [Abstract][Full Text] [Related]
39. MiR-185 attenuates androgen receptor function in prostate cancer indirectly by targeting bromodomain containing 8 isoform 2, an androgen receptor co-activator.
Jiang CY; Ruan Y; Wang XH; Zhao W; Jiang Q; Jing YF; Han BM; Xia SJ; Zhao FJ
Mol Cell Endocrinol; 2016 May; 427():13-20. PubMed ID: 26940039
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-1297 inhibits prostate cancer cell proliferation and invasion by targeting the AEG-1/Wnt signaling pathway.
Liang X; Li H; Fu D; Chong T; Wang Z; Li Z
Biochem Biophys Res Commun; 2016 Nov; 480(2):208-214. PubMed ID: 27746178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
